DGAP-News 276 0 Kommentare Announcement: 4SC to host conference call on 6 November 2014 to present third quarter results of 2014

DGAP-News: 4SC AG / Key word(s): Miscellaneous
Announcement: 4SC to host conference call on 6 November 2014 to
present third quarter results of 2014

30.10.2014 / 15:00

---------------------------------------------------------------------

Announcement

4SC to host conference call on 6 November 2014 to present third quarter
results of 2014

Planegg-Martinsried, Germany, 30 October 2014 - 4SC AG (Frankfurt, Prime
Standard: VSC), a discovery and development company of targeted small
molecule drugs for cancer and autoimmune diseases, will announce third
quarter results 2014 of the 4SC Group and publish the company's report on
the first nine months of 2014 on 6 November 2014. On this day the
Management Board of 4SC AG will host a conference call at 3pm CET (9am EST)
to inform about the consolidated financial statements and important
developments in the reporting period and beyond.

Investors, financial analysts, and journalists participating in the
conference call can access via the following telephone numbers:

Date: 6 November 2014
Time: 3pm CET (9am EST)
Dial-in numbers:
+49-89-1214 00698 (Germany)
+44-20 3427 1929 (UK)
+1-646 254 3387 (USA)
+49-89-1214 00698 (other countries)
Conference ID: 6125329

After the conference call a replay will be available in the section
"Investors" / "Events & Presentations" / "Conference Calls & Webcasts" of
the website www.4sc.com.

Ends

About 4SC

The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops
targeted, small-molecule drugs for treating diseases with high unmet
medical needs in various cancer and autoimmune indications. These drugs are
intended to provide innovative treatment options that are more tolerable
and efficacious than existing therapies, and provide a better quality of
life. The Company's pipeline comprises promising products that are in
various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
pharmaceutical and biotech companies. Founded in 1997, 4SC had a headcount
of 65 employees (55 FTEs) at 30 September 2014. 4SC AG has been listed on
the Prime Standard of the Frankfurt Stock Exchange since December 2005.

Cautionary statement regarding forward-looking statements

This press release contains certain forward-looking statements. Any
forward-looking statement applies only on the date of this press release.
By their nature, forward-looking statements are subject to a number of
known and unknown risks and uncertainties that may or may not occur in the
future and as a result of which the actual results and performance may
differ substantially from the expected future results or performance
expressed or implied in the forward looking statements. No warranties or
representations are made as to the accuracy, achievement or reasonableness
of such statements, estimates or projections, and 4SC AG has no obligation
to update any such information or to correct any inaccuracies herein or
omission herefrom which may become apparent.

For more information please visit www.4sc.com or contact:

4SC AG
Jochen Orlowski, Corporate Communications & Investor Relations
jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366

MC Services
Katja Arnold, Michelle Kremer
katja.arnold(at)mc-services.eu, Tel.: +49-89-2102-2840

The Trout Group
Chad Rubin
crubin(at)troutgroup.com, Tel.: +1-646-378-2947

---------------------------------------------------------------------

30.10.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------

Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Martinsried
Germany
Phone: +49 (0)89 7007 63-0
Fax: +49 (0)89 7007 63-29
E-mail: public@4sc.com
Internet: www.4sc.de
ISIN: DE0005753818
WKN: 575381
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service
---------------------------------------------------------------------
294180 30.10.2014